Objective. The YY1 mutation has been suggested as one of the indicators tha
t explains development of cervical neoplasia by episomal-type HPV. To exten
d this hypothesis, we examined whether a mutation(s) in the YY1 site is fun
ctionally related to the invasiveness of cervical neoplasia and the physica
l status of HPV DNA,
Methods. The URR sequences were obtained by PCR amplification of HPV-16 gen
ome from CIN and invasive cancer patients and cloned into pUC18 for sequenc
ing and into pBLCAT8+ for functional CAT assay.
Results. Our previous data classified HPV-infected patients into three grou
ps: 3 cancer cases carrying episomal HPV DNA; 12 cancer cases carrying inte
grated HPV DNA; 12 CIN cases carrying episomal HPV DNA, The specific varian
ts in HPV-16 URR were found in Korean women: G-->A transition at nt 7520 (1
00%, 27/27), A-->C transition at nt 7729 (70%; 19/27), and G-->A transition
at nt 7841 (78%; 21/27), Selective mutations were observed at the YY1 bind
ing sites of HPV-16 URR in the 3 patients with invasive cervical cancer who
have the episomal forms of HPV-16 DNA: A-->C transition at nt 7484 and G--
>A transition at nt 7488 (YY1-binding site 2; from 7481 to 7489), Additiona
lly, C-->T transition at nt 7785 (YY1-binding site 3; from 7781 to 7790) wa
s found in 2 of 3 patients. No YY1 site mutations were detected in the 12 C
IN patients and in the HPV-integrated invasive cancer patients. To determin
e whether these mutations have effects on the expression of HPV E6/E7 genes
driven by URR, the transient transfection assay was employed using URR-CAT
reporter plasmid. The relative activities of three URR mutants from episom
al HPV-16 DNA of cervical cancers were two- to fourfold higher than that of
the HPV-16 URR prototype. In contrast, the URRs from integrated HPV-16 DNA
in cervical cancer and from episomal HPV-16 DNA in GIN, where no mutation
of the YY1 binding site was detected, showed similar levels of promoter act
ivity to that of the URR prototype.
Conclusions. Our results support the hypothesis that the mutation at the YY
1 binding site is functionally related to the development of cervical neopl
asia caused by episomal HPV-16 DNA in Korean cervical cancer patients. Thus
, mutation in the YY1 site of episomal HPV-16 URR may play a corresponding
role of HPV integration in the progression of cervical cancer. (C) 1999 Aca
demic Press.